Dr. Heidi Overton, nominated to lead the Food and Drug Administration, appeared before a Senate confirmation hearing on Thursday. Her record on abortion pills, vaccines, and food safety drew sharp questions from lawmakers. Overton has publicly described mifepristone as dangerous to women.
Mifepristone is one of two drugs used in medication abortion. It has been approved in the United States for more than two decades. Major medical groups consider it safe and effective when used as directed.
Overton previously served as a White House aide. In that role, she worked to reduce the number of vaccines recommended for children. Her efforts focused on the federal immunization schedule. Public health officials have defended that schedule as essential.
Senators pressed Overton on whether she would follow scientific evidence at the agency. She said she would review data and consult career experts. Critics noted her past statements suggest otherwise.
The FDA oversees drug approvals, vaccine safety, and the nation’s food supply. Its decisions affect millions of Americans every day. The agency also regulates tobacco and medical devices.
Food safety advocates raised concerns about Overton’s limited record on the topic. They pointed to recent outbreaks linked to contaminated produce and infant formula. The agency has faced criticism for slow responses to such incidents.
Overton’s nomination has divided public health experts and lawmakers. Supporters say she brings a fresh perspective to the agency. Opponents argue her views conflict with established medical consensus.
The Senate has not yet scheduled a vote on her confirmation. A final decision could take several weeks. If confirmed, Overton would oversee an agency with roughly 18,000 employees.
